Mary Kathryn(Duncan)MalecekMD

PubMed

• 42 citations
  Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
  Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow, Mary-Kate Malecek, Marcus P Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana H. ...> ;Blood. 2021 Sep 27
• 21 citations
  Early Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.
  David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bha...> ;Blood Advances. 2021 Sep 13
• 9 citations
  Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
  Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J Voorhees, Natalie S Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T...> ;Blood Advances. 2021 Sep 28
• 11 citations
  Multi-Center Analysis of Practice Patterns and Outcomes of Younger and Older Patients with Mantle Cell Lymphoma in the Rituximab Era.
  Reem Karmali, Jeffrey M. Switchenko, Subir Goyal, Krithika Shanmugasundaram, Michael C. Churnetski, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta...> ;American Journal of Hematology. 2021 Jul 29
• 3 citations
  Intensive Induction Regimens after Deferring Initial Therapy for Mantle Cell Lymphoma Are Not Associated with Improved Survival
  Krithika Shanmugasundaram, Subir Goyal, J. Switchenko, Oscar Calzada, Michael C. Churnetski, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J...> ;European Journal of Haematology. 2021 May 11
• 3 citations
  Prognosis and risk stratification of peripheral T-cell lymphomas.
  Mary-Kate Malecek, Neha Mehta-Shah> ;Seminars in Hematology. 2021 Feb 11
• 7 citations
  Polatuzumab vedotin for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma.
  Mary-Kate Malecek, Marcus Watkins, Nancy L. Bartlett> ;Expert Opinion on Biological Therapy. 2021 Jul 3
• 4 citations
  Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment.
  Mary-Kate Malecek, Mark A. Fiala, Mark A. Schroeder, James Dukeman, Armin Ghobadi, Keith Stockerl-Goldstein, Tanya M. Wildes, Ravi Vij> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Sep 1
• 8 citations
  Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab
  Mary-Kate Malecek, Adam M. Petrich, Shaina Rozell, Benjamin Chu, Steven Trifilio, Natalie Galanina, Matthew J. Maurer, Umar Farooq, Brian K. Link, Grzegorz S. Nowakows...> ;American Journal of Hematology. 2017 Aug 17
• Advancements in unresectable melanoma: a multidisciplinary perspective
  Mary-Kate Malecek, June K. Robinson, Karl Y. Bilimoria, Jennifer N. Choi, Jaehyuk Choi, Pedram Gerami, Tim J. Kruser, Timothy M. Kuzel, Mary C. Martini, Jonathan B. St...> ;Melanoma Management. 2016 Aug 16
• 227 citations
  Repurposing metformin for cancer treatment: current clinical studies
  Young Kwang Chae, Ayush Arya, Mary-Kate Malecek, Daniel Sanghoon Shin, Benedito A. Carneiro, Sunandana Chandra, Jason B. Kaplan, Aparna Kalyan, Jessica K. Altman, Leon...> ;Oncotarget. 2016 Mar 19
• 29 citations
  Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit?
  Young Kwang Chae, Muhammad Yousaf, Mary-Kate Malecek, Benedito A. Carneiro, Sunandana Chandra, Jason B. Kaplan, Aparna Kalyan, Antonella Sassano, Leonidas C. Platanias...> ;Discovery Medicine. 2015 Jan 1
• Join now to see all

Abstracts/Posters

• Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all